keyword
Keywords Metastasic breast cancer surgi...

Metastasic breast cancer surgical management

https://read.qxmd.com/read/38611103/the-impact-of-adjunct-medical-therapy-on-survival-after-spine-metastasis-a-systematic-review-and-pooled-data-analysis
#1
REVIEW
Lilly Groszman, Jonathan A Hubermann, Paul Kooner, Nawaf Alamiri, Anthony Bozzo, Ahmed Aoude
Targeted therapy has greatly improved the outlook for patients with spinal metastatic cancers. Scoring systems like the Tokuhashi or Tomita scores are commonly used to predict prognosis and inform surgical decisions, but they are outdated and fail to consider recent advancements. We aimed to investigate the current state of the literature and treatment options pertaining to advancements in targeted therapy compared to other forms of medical management for metastatic spinal tumors. This study represents the first comprehensive systematic review that encompasses the most common primary cancers that metastasize to the spine and evaluates the median overall survival (mOS) across five different medical treatment modalities as well as surgical intervention...
April 7, 2024: Cancers
https://read.qxmd.com/read/38529608/liposomal-nano-based-drug-delivery-systems-for-breast-cancer-therapy-recent-advances-and-progresses
#2
JOURNAL ARTICLE
Mostafa Yazdan, Seyed Morteza Naghib, M R Mozafari
Breast cancer is a highly prevalent disease on a global scale, with a 30% incidence rate among women and a 14% mortality rate. Developing countries bear a disproportionate share of the disease burden, while countries with greater technological advancements exhibit a higher incidence. A mere 7% of women under the age of 40 are diagnosed with breast cancer, and the prevalence of this ailment is significantly diminished among those aged 35 and younger. Chemotherapy, radiation therapy, and surgical intervention comprise the treatment protocol...
March 25, 2024: Anti-cancer Agents in Medicinal Chemistry
https://read.qxmd.com/read/38506114/stress-in-the-metastatic-journey-the-role-of-cell-communication-and-clustering-in-breast-cancer-progression-and-treatment-resistance
#3
JOURNAL ARTICLE
Eloïse M Grasset, Sophie Barillé-Nion, Philippe P Juin
Breast cancer stands as the most prevalent malignancy afflicting women. Despite significant advancements in its diagnosis and treatment, breast cancer metastasis continues to be a leading cause of mortality among women. To metastasize, cancer cells face numerous challenges: breaking away from the primary tumor, surviving in the circulation, establishing in a distant location, evading immune detection and, finally, thriving to initiate a new tumor. Each of these sequential steps requires cancer cells to adapt to a myriad of stressors and develop survival mechanisms...
March 1, 2024: Disease Models & Mechanisms
https://read.qxmd.com/read/38433867/the-mareca-national-study-of-management-of-breast-cancer-locoregional-recurrence-and-oncological-outcomes-study-protocol-for-a-prospective-multicentre-cohort-study
#4
JOURNAL ARTICLE
Sue M Hartup, Jenna L Morgan, Vinton Wt Cheng, Peter A Barry, Ellen Copson, Ramsey I Cutress, Rajiv Dave, Beatrix Elsberger, Patricia Fairbrother, Brian Hogan, Kieran Horgan, Cliona C Kirwan, Stuart A McIntosh, Rachel L O'Connell, Neill Patani, Shelley Potter, Tim Rattay, Lisa Sheehan, Lynda Wyld, Baek Kim
BACKGROUND: Despite a UK 5-year breast cancer survival rate of 86.6%, patients may develop breast cancer recurrence within the same breast after breast conserving surgery, as well as in the remaining skin or chest wall after mastectomy or in the ipsilateral lymph glands. These recurrences, collectively termed locoregional recurrence (LRR), occur in around 8% of patients within 10 years of their original diagnosis. Currently, there is a lack of robust information on the presentation and prevalence of LRR with no UK-specific clinical guidelines available for the optimal management of this patient group...
March 2024: International journal of surgery protocols
https://read.qxmd.com/read/38412597/abducens-nerve-palsy-due-to-clivus-metastasis-in-a-patient-with-breast-carcinoma-a-rare-case
#5
Jude Selvakumar Nilojan, Sittampalam Rajendra, Gayathri Naganathan
INTRODUCTION: Breast cancer, comprising 25 % of all diagnosed cancers, predominantly affects women globally. While bone metastasis is common, occurrences at the clivus or skull base are rarely documented. Treatment varies from surgery in early stages to a multifaceted approach for advanced cases, incorporating chemotherapy, radiotherapy, and surgery based on staging and histology. CLINICAL PRESENTATION: A 40-year-old female presented with a rapidly enlarging lump in her left breast and diplopia on right gaze...
February 25, 2024: International Journal of Surgery Case Reports
https://read.qxmd.com/read/38355870/the-role-of-spine-stereotactic-radiosurgery-for-patients-with-breast-cancer-metastases
#6
JOURNAL ARTICLE
Suchet Taori, Samuel Adida, Anthony Tang, Akshath Rajan, Roberta K Sefcik, Steven A Burton, John C Flickinger, Pascal O Zinn, Peter C Gerszten
PURPOSE: Breast cancer that metastasizes to the spine is associated with low quality of life and poor survival. Radiosurgery has an increasing role in this patient population. This single-institution (2003-2023) study analyzes clinical outcomes and prognostic factors for patients who underwent spinal stereotactic radiosurgery (SSRS) for metastatic breast cancer. METHODS: Ninety patients (155 unique breast cancer spinal metastases) were treated with SSRS. The median age was 57 years (range: 35-88), and the median KPS was 80 (range: 40-100)...
February 14, 2024: Journal of Neuro-oncology
https://read.qxmd.com/read/38331453/diagnostic-accuracy-of-68-ga-fapi-versus-18-f-fdg-pet-in-patients-with-various-malignancies
#7
JOURNAL ARTICLE
Nader Hirmas, Rainer Hamacher, Miriam Sraieb, Lukas Kessler, Kim M Pabst, Francesco Barbato, Helena Lanzafame, Stefan Kasper, Michael Nader, Claudia Kesch, Bastian von Tresckow, Hubertus Hautzel, Clemens Aigner, Martin Glas, Martin Stuschke, Sherko Kümmel, Philipp Harter, Celine Lugnier, Waldemar Uhl, Boris Hadaschik, Viktor Grünwald, Jens T Siveke, Ken Herrmann, Wolfgang P Fendler
To assess the diagnostic accuracy of 68 Ga-labeled fibroblast activation protein inhibitor (FAPI) and 18 F-labeled FDG PET for the detection of various tumors, we performed a head-to-head comparison of both imaging modalities across a range of tumor entities as part of our ongoing 68 Ga-FAPI PET observational trial. Methods: The study included 115 patients with 8 tumor entities who received imaging with 68 Ga-FAPI for tumor staging or restaging between October 2018 and March 2022. Of those, 103 patients received concomitant imaging with 68 Ga-FAPI and 18 F-FDG PET and had adequate lesion validation for accuracy analysis...
February 8, 2024: Journal of Nuclear Medicine
https://read.qxmd.com/read/38229789/receptor-positive-breast-lesions-and-status-of-axillary-lymph-node
#8
JOURNAL ARTICLE
Vinod Kumar Singhal
Objective This study aimed to examine the axillary pathological condition through the development of an assessment framework for hormone receptor-positive breast cancer subsequent to neoadjuvant chemotherapy (NAC). Furthermore, the primary objective of this study was to examine the association between axillary status and breast tumors that are positive for hormone receptors following neoadjuvant chemotherapy. Methodology The present retrospective investigation encompassed a cohort including 300 individuals who were administered neoadjuvant chemotherapy before receiving surgical intervention...
December 2023: Curēus
https://read.qxmd.com/read/38217839/axillary-nodal-staging-in-breast-cancer-what-have-we-learned
#9
REVIEW
Theresa L Schwartz
Axillary management in patients with breast cancer is in a constant state of evolution. To provide appropriate treatment recommendations, we must understand the historical implications and the current indications for nodal staging as well as the clinical implications of nodal metastases. As we move away from maximal axillary surgical intervention that was previously the mainstay of breast cancer management, future research efforts will focus on targeted therapies based on tumor biology and identifying oncologically safe methods to de-escalate our management strategies...
January 13, 2024: Clinical & Experimental Metastasis
https://read.qxmd.com/read/38127216/surgeon-perspectives-on-the-management-of-aborted-cancer-surgery-results-of-a-society-of-surgical-oncology-member-survey
#10
JOURNAL ARTICLE
Alexandra G Lopez-Aguiar, Angela Sarna, Sharla Wells-DiGregorio, Emily Huang, Peter J Kneuertz, Joal Beane, Alex Kim, Aslam Ejaz, Timothy M Pawlik, Jordan M Cloyd
BACKGROUND: While surgery is generally necessary for most solid-organ cancers, curative-intent resection is occasionally aborted due to unanticipated unresectability or occult metastases. Following aborted cancer surgery (ACS), patients have unique and complex care needs and yet little is known about the optimal approach to their management. OBJECTIVE: The aim of this study was to define the practice patterns and perspectives of an international cohort of cancer surgeons on the management of ACS...
December 21, 2023: Annals of Surgical Oncology
https://read.qxmd.com/read/38122844/-updated-surgical-indications-and-quality-and-safety-indicators-in-the-management-of-infiltrative-breast-carcinoma
#11
JOURNAL ARTICLE
Carole Mathelin, Susie Brousse, Martin Schmitt, Nicolas Taris, Catherine Uzan, Sébastien Molière, Charlotte Vaysse
OBJECTIVES: Breast surgery is the cornerstone of breast cancer treatment. Its indications and procedures are constantly evolving. To update best practices, four questions were submitted to the Senology Commission (SC) of the Collège National des Gynécologues et Obstétriciens Français (CNGOF), covering the indications and modalities of tumor surgery 1) initially, 2) following neoadjuvant systemic treatment, 3) in case of local recurrence, and 4) the quality and safety of care indicators applicable to this surgery...
December 18, 2023: Gynecologie, Obstetrique, Fertilite & Senologie
https://read.qxmd.com/read/38083869/surgical-resection-of-soft-tissue-metastasis-in-cancers-a-single-center-study-of-77-cases-over-a-7-year-period
#12
JOURNAL ARTICLE
Qingrong Ye, Tu Hu, Zhengwang Sun, Peihang Xu, Chunmeng Wang, Yangbai Sun, Wangjun Yan
INTRODUCTION: Soft tissue metastasis (STM) of cancers, encompassing skeletal muscle and subcutaneous tissue metastasis, is less common due to unique homeostatic conditions. With longer life expectancy and the advent of new imaging modalities, clinical physicians will increasingly encounter and manage such cases. This study retrospectively reviewed cases of STM in visceral cancers who underwent surgery at Fudan University Shanghai Cancer Center over a 7-year period. METHODS: Data were collected through a comprehensive review of medical records, including demographic variables, primary tumor characteristics, surgical data, tumor pathology, and outcomes...
December 11, 2023: Cancer Medicine
https://read.qxmd.com/read/38074672/trends-in-surgical-management-of-spinal-metastases-in-a-singaporean-tertiary-referral-center-a-17-year-retrospective-review
#13
JOURNAL ARTICLE
Jiong Hao Jonathan Tan, James Thomas Patrick Decourcy Hallinan, Renick Lee, Yiong Huak Chan, Tuan Hao Tan, Shi Wei Ang, Le Tian Isaac Tan, Joelle Hwee Inn Tan, Qinxiang Shant Sin, Dennis Hwee Weng Hey, Leok Lim Lau, Joseph Thambiah, Hee Kit Wong, Gabriel Liu, Naresh Kumar
INTRODUCTION: Surgical treatment is increasingly the treatment of choice in cancer patients with epidural spinal cord compression and spinal instability. There has also been an evolution in surgical treatment with the advent of minimally invasive surgical (MIS) techniques and separation surgery. This paper aims to investigate the changes in epidemiology, surgical technique, outcomes and complications in the last 17 years in a tertiary referral center in Singapore. METHODS: This is a retrospective study of 383 patients with surgically treated spinal metastases treated between January 2005 to January 2022...
2023: Frontiers in Oncology
https://read.qxmd.com/read/38061088/simultaneous-cutaneous-melanoma-and-ipsilateral-breast-cancer-with-metastasis-to-the-same-axilla-a-case-report-with-a-focus-on-a-multidisciplinary-approach
#14
Margit Leonie Riis, Linnea Augestad, Vidar Gordon Flote, Aase Tangerud, Lars Frich
INTRODUCTION AND IMPORTANCE: Treatment of simultaneously occurring primary malignancies with separate lymphatic drainage is a surgical and medical challenge. We present a patient in which multidisciplinary management of coexisting melanoma and breast cancer was mandatory for optimal results. CASE PRESENTATION: A 67-year-old female had a primary surgical resection for a skin lesion on the back. Histology revealed melanoma with a Breslow thickness of 4.8 mm. According to guidelines, a wide local excision was scheduled...
January 2024: International Journal of Surgery Case Reports
https://read.qxmd.com/read/38048724/breast-surgery-for-patients-with-de-novo-metastatic-breast-cancer-a-meta-analysis-of-randomized-controlled-trials
#15
REVIEW
Chongxi Ren, Jianna Sun, Lingjun Kong, Hongqiao Wang
The role of breast surgery in the treatment of patients with de novo metastatic breast cancer(dnMBC) remains controversial, with conflicting trial results. We did a meta-analysis to comprehensively investigate and assess whether breast surgery is associated with survival and quality of life outcomes in patients with dnMBC.We systematically searched PubMed, Embase, Google Scholar, Scopus, and Web of Science, from database inception to March 30, 2022, for randomized controlled trials(RCTs) that compared breast surgery or locoregional therapy with non-surgical treatment based on systemic therapy for managing dnMBC...
January 2024: European Journal of Surgical Oncology
https://read.qxmd.com/read/38011864/management-of-brain-metastases-a-review-of-novel-therapies
#16
REVIEW
Shreyas Bellur, Atulya Aman Khosla, Ahmad Ozair, Rupesh Kotecha, Michael W McDermott, Manmeet S Ahluwalia
Brain metastases (BMs) represent the most common intracranial tumors in adults, and most commonly originate from lung, followed by breast, melanoma, kidney, and colorectal cancer. Management of BM is individualized based on the size and number of brain metastases, the extent of extracranial disease, the primary tumor subtype, neurological symptoms, and prior lines of therapy. Until recently, treatment strategies were limited to local therapies, like surgical resection and radiotherapy, the latter in the form of whole-brain radiotherapy or stereotactic radiosurgery...
December 2023: Seminars in Neurology
https://read.qxmd.com/read/38009875/comprehensive-clinical-literature-review-of-managing-bone-metastases-in-breast-cancer-focus-on-pain-and-skeletal-related-events
#17
REVIEW
Kawther Hamash, Suzanne L Walker
BACKGROUND: Bone metastases are the most common site of metastatic disease in breast cancer and can result in significant pain and an increased risk of skeletal-related events (SREs). Uncontrolled pain can further lead to negative outcomes. OBJECTIVES: The aim is to provide oncology nurses with the latest evidence on the management of bone metastases in metastatic breast cancer (MBC) with a focus on pain and SREs. METHODS: A literature search was conducted using the Embase®, PubMed®/MEDLINE®, CINAHL®, and Cochrane Library databases...
November 16, 2023: Clinical Journal of Oncology Nursing
https://read.qxmd.com/read/37973647/axillary-nodal-metastases-conversion-and-perioperative-complications-with-neoadjuvant-pembrolizumab-therapy-in-triple-negative-breast-cancer
#18
JOURNAL ARTICLE
Ashley A Woodfin, Clinton Yam, Mediget Teshome, Henry M Kuerer, Kelly K Hunt, Funda Meric-Bernstam, Mark Schaverien, Carlos H Barcenas, Susie X Sun
BACKGROUND: Triple-negative breast cancer (TNBC) is known to portend a worse prognosis compared with same-stage, hormone receptor-positive disease. However, with the recent change in practice to include pembrolizumab in neoadjuvant chemotherapy (NAC) for TNBC, an increase in pathologic complete responses (pCRs) has been reported. The perioperative repercussions of adding pembrolizumab to standard NAC regimens for TNBC are currently unknown. We aimed to explore the perioperative implications of adding pembrolizumab to standard NAC regimens for non-metastatic TNBC...
November 16, 2023: Annals of Surgical Oncology
https://read.qxmd.com/read/37945819/safety-of-microneurosurgical-interventions-for-superficial-and-deep-seated-brain-metastases-single-center-cohort-study-of-637-consecutive-cases
#19
JOURNAL ARTICLE
Stefanos Voglis, Luis Padevit, Christiaan Hendrik Bas van Niftrik, Vincens Kälin, Benjamin Beyersdorf, Raffaele Da Mutten, Vittorio Stumpo, Jacopo Bellomo, Johannes Sarnthein, Victor Egon Staartjes, Alessandro Carretta, Niklaus Krayenbühl, Luca Regli, Carlo Serra
PURPOSE: Microneurosurgical techniques have greatly improved over the past years due to the introduction of new technology and surgical concepts. To reevaluate the role of micro-neurosurgery in brain metastases (BM) resection in the era of new systemic and local treatment options, its safety profile needs to be reassessed. The aim of this study was to analyze the rate of adverse events (AEs) according to a systematic, comprehensive and reliably reproducible grading system after microneurosurgical BM resection in a large and modern microneurosurgical series with special emphasis on anatomical location...
November 10, 2023: Journal of Neuro-oncology
https://read.qxmd.com/read/37916188/role-of-aggressive-locoregional-surgery-in-treatment-strategies-for-ipsilateral-supraclavicular-lymph-node-metastasis-of-breast-cancer-a-real-world-cohort-study
#20
JOURNAL ARTICLE
Kexin Feng, Zeyu Xing, Qichen Dai, Han Cheng, Xiang Wang
Background: Breast cancer patients with synchronous ipsilateral supraclavicular lymph node metastases (ISLNM) have unfavorable prognoses. The role of supraclavicular lymph node dissection (SLND) as a surgical intervention in the treatment of this condition remains controversial. In this study, we aimed to evaluate the prognostic factors associated with breast cancer with ISLNM and to assess the potential impact of aggressive locoregional surgical management on patient outcomes. Methods: We conducted a retrospective analysis of 250 breast cancer patients with ISLNM who were treated with curative intent at our institution between 2000 and 2020...
2023: Frontiers in Molecular Biosciences
keyword
keyword
49705
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.